Publication details
Vývoj medikamentózní terapie ED - minulost, současnost, budoucnost
| Title in English | DEVELOPMENT OF MEDICAMENTOUS THERAPY OF ED - PAST, PRESENT AND FUTURE |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Urologické listy |
| MU Faculty or unit | |
| Citation | |
| Field | Other specializations of internal medicine |
| Keywords | erectile dysfunction; PDE5 inhibitors; PGE1 prostaglandin |
| Description | Modern treatment of erectile dysfunction consists mainly of PDE5 inhibitors as the drugs of first choice. They are the easiest to administer with a quick effect. This includes sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) and avanafil (Stendra). Second-line therapy includes intracavernous or intraurethral submission of prostaglandin. Other modern methods, such as gene therapy, are also promising, but further studies are needed for their validation and application in practice. |